143
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Molecular Identification, and Characterization of Mycobacterium kansasii Strains Isolated from Four Tuberculosis Regional Reference Laboratories in Iran During 2016–2018

ORCID Icon, , ORCID Icon &
Pages 2171-2180 | Published online: 07 Jul 2020

References

  • Jeon D. Infection source and epidemiology of nontuberculous mycobacterial lung disease. Tuberc Respir Dis (Seoul). 2019;82(2):94–101. doi:10.4046/trd.2018.002630302953
  • Forbes BA. Mycobacterial taxonomy. J Clin Microbiol. 2017;55(2):380–383. doi:10.1128/JCM.01287-1627927928
  • McShane PJ, Glassroth J. Pulmonary disease due to nontuberculous mycobacteria: current state and new insights. Chest. 2015;148(6):1517–1527. doi:10.1378/chest.15-045826225805
  • Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Shahraki AH. Prevalence of non-tuberculosis mycobacterial infections among tuberculosis suspects in Iran: systematic review and meta-analysis. PLoS One. 2015;10(6):e0129073. doi:10.1371/journal.pone.012907326052701
  • Mortazavi Z, Bahrmand A, Sakhaee F, et al. Evaluating the clinical significance of nontuberculous mycobacteria isolated from respiratory samples in Iran: an often overlooked disease. Infect Drug Resist. 2019;12:1917–1927. doi:10.2147/IDR.S21418131308711
  • Johnston JC, Chiang L, Elwood K. Mycobacterium kansasii. Microbiol Spectr. 2017;5:1. doi:10.1128/microbiolspec.TNMI7-0011-2016
  • Bakuła Z, Safianowska A, Nowacka-Mazurek M, Bielecki J, Jagielski T. Subtyping of mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene. Biomed Res Int. 2013;2013.
  • Okoi C, Anderson STB, Antonio M, Mulwa SN, Gehre F, Adetifa IMO. Non-tuberculous Mycobacteria isolated from pulmonary samples in sub-Saharan Africa - a systematic review and meta analyses. Sci Rep. 2017;7(1):12002. doi:10.1038/s41598-017-12175-z28931915
  • Falkinham JO 3rd. Current epidemiologic trends of the nontuberculous mycobacteria (NTM). Curr Environ Health Rep. 2016;3(2):161–167.27020801
  • Nasiri MJ, Dabiri H, Fooladi AA, Amini S, Hamzehloo G, Feizabadi MM. High rates of nontuberculous mycobacteria isolation from patients with presumptive tuberculosis in Iran. New Microbes New Infect. 2018;21:12–17. doi:10.1016/j.nmni.2017.08.00829188063
  • Philley JV, DeGroote MA, Honda JR, et al. Treatment of non-tuberculous mycobacterial lung disease. Curr Treat Options Infect Dis. 2016;8(4):275–296. doi:10.1007/s40506-016-0086-428529461
  • Matveychuk A, Fuks L, Priess R, Hahim I, Shitrit D. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Respir Med. 2012;106(10):1472–1477. doi:10.1016/j.rmed.2012.06.02322850110
  • Liang B, Du C, Tian X, et al. Rapid identification of clinically relevant Mycobacterium species by multicolor melting curve analysis. J Clin Microbiol. 2019;57(1).
  • Dai J, Chen Y, Dean S, Morris JG, Salfinger M, Johnson JA. Multiple-genome comparison reveals new loci for Mycobacterium species identification. J Clin Microbiol. 2011;49(1):144–153. doi:10.1128/JCM.00957-1021048007
  • Bakuła Z, Brzostek A, Borówka P, et al. Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis. Sci Rep. 2018;8(1):4462. doi:10.1038/s41598-018-21562-z29535391
  • Bakuła Z, Kościuch J, Safianowska A, et al. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease. Respir Med. 2018;139:91–100. doi:10.1016/j.rmed.2018.05.00729858008
  • Bakuła Z, Modrzejewska M, Safianowska A, et al. Proposal of a new method for subtyping of Mycobacterium kansasii based upon PCR restriction enzyme analysis of the tuf gene. Diagn Microbiol Infect Dis. 2016;84(4):318–321. doi:10.1016/j.diagmicrobio.2015.12.00926830053
  • Huang CC, Chen JH, Hu ST, et al. Combined rpoB duplex PCR and hsp65 PCR restriction fragment length polymorphism with capillary electrophoresis as an effective algorithm for identification of mycobacterial species from clinical isolates. BMC Microbiol. 2012;12:137. doi:10.1186/1471-2180-12-13722769981
  • Iwamoto T, Saito H. Comparative study of two typing methods hsp65 PRA and ITS sequencing revealed a possible evolutionary link between Mycobacterium kansasii type I and II isolates. FEMS Microbiol Lett. 2005;254:129–133. doi:10.1111/j.1574-6968.2005.00013.x
  • Jagielski T, Borówka P, Bakuła Z, et al. Genomic insights into the Mycobacterium kansasii complex: an update. Front Microbiol. 2020;10:2918. doi:10.3389/fmicb.2019.0291832010067
  • Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST17277290
  • Mahon CR, Lehman DC, Manuselis G Jr. Textbook of Diagnostic Microbiology. St. Louis, MI: Saunders; 2014.
  • Adékambi T, Colson P, Drancourt M. rpoB-based identification of non-pigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol. 2003;41(12):5699–5708. doi:10.1128/JCM.41.12.5699-5708.200314662964
  • Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–1874. doi:10.1093/molbev/msw05427004904
  • Falkinham JO. Current epidemiologic trends of the nontuberculous mycobacteria (NTM). Curr Environ Health Rep. 2016;3(2):161–167.27020801
  • Winthrop KL, Henkle E, Walker A, Cassidy M, Hedberg K, Schafer S. On the reportability of nontuberculous mycobacterial disease to public health authorities. Ann Am Thorac Soc. 2017;14(3):314–317. doi:10.1513/AnnalsATS.201610-802PS27997817
  • Velayati AA, Farnia P, Mozafari M, et al. Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city. PLoS One. 2014;9(12):e114428. doi:10.1371/journal.pone.011442825485795
  • Khosravi AD, Hashemi Shahraki A, Hashemzadeh M, Sheini Mehrabzadeh R, Teimoori A. Prevalence of non-tuberculous mycobacteria in hospital waters of major cities of Khuzestan Province, Iran. Front Cell Infect Microbiol. 2016;6:42. doi:10.3389/fcimb.2016.0004227148491
  • Kim SH, Shin JH. Identification of nontuberculous mycobacteria using multilocus sequence analysis of 16S rRNA, hsp65, and rpoB. J Clin Lab Anal. 2018;32(1):e22184. doi:10.1002/jcla.22184
  • Shahraki AH, Trovato A, Mirsaeidi M, et al. Mycobacterium persicum sp. nov., a novel species closely related to Mycobacterium kansasii and Mycobacterium gastri. Int J Syst Evol Microbiol. 2017;67(6):1766–1770. doi:10.1099/ijsem.0.00186228629501
  • Hoefsloot W, Van Ingen J, Andrejak C, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–1613. doi:10.1183/09031936.0014921223598956
  • Kobashi Y, Mouri K, Miyashita N, Oka M. Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease. Jpn J Infect Dis. 2009;62:239–241.19468192
  • Van Halsema CL, Chihota VN, Gey van Pittius NC, et al. Clinical relevance of nontuberculous mycobacteria isolated from sputum in a gold mining workforce in South Africa: an observational, clinical study. Biomed Res Int. 2015;2015.
  • Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci. 2005;20(6):957–960. doi:10.3346/jkms.2005.20.6.95716361804
  • Li Y, Pang Y, Tong X, Zheng H, Zhao Y, Wang C. Mycobacterium kansasii subtype I is associated with clarithromycin resistance in China. Front Microbiol. 2016;7:2097. doi:10.3389/fmicb.2016.0209728082964
  • Thomson R, Tolson C, Huygens F, Hargreaves M. Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR. Int J Med Microbiol. 2014;304(3–4):484–489. doi:10.1016/j.ijmm.2014.02.00424636860
  • Taillard C, Greub G, Weber R, et al. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol. 2003;41(3):1240–1244. doi:10.1128/JCM.41.3.1240-1244.200312624057
  • da Silva Telles MA, Chimara E, Ferrazoli L, Riley LW. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates. J Med Microbiol. 2005;54(10):975–979. doi:10.1099/jmm.0.45965-016157553
  • Santin M, Alcaide F, Benitez MA, et al. Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain. Epidemiol Infect. 2004;132(3):425–432. doi:10.1017/S095026880300150X15188712
  • Tortoli E, Simonetti MT, Lacchini C, Penati V, Urbano P. Tentative evidence of AIDS-associated biotype of Mycobacterium kansasii. J Clin Microbiol. 1994;32(7):1779–1782. doi:10.1128/JCM.32.7.1779-1782.19947929774